- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ketamine
Recent news which mentions ketamine
Credit Memberships Open New Doors for Wellness Journeys
August 30, 2022
From PRUnderground
From PRUnderground
How Does Ketamine Affect The Brain Over Time?
June 25, 2022
From Benzinga
From PRUnderground
EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues
May 18, 2022
From Benzinga
From Benzinga
EXCLUSIVE: Bexson Biomedical Inks Agreement With Stevanato For Delivery System Of Ketamine In Pain Management
April 28, 2022
From Benzinga
How a 3D Body Scanner Customizes Wellness Journeys
April 22, 2022
From PRUnderground
These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)
April 06, 2022
From Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
Tickers
CYBN
From Benzinga
Top 5 Most Influential Psychedelic Studies
March 29, 2022
From Benzinga
Klee Irwin Of Irwin Naturals At The Forefront Of 'Psychedelics Renaissance': Meet Our Keynote Speakers
March 17, 2022
From Benzinga
From PRUnderground
From PRUnderground
From Benzinga
Texas Further Embraces Psychedelics With Launch Of Center For Psychedelic Research And Therapy
January 29, 2022
Tickers
MDMA
From Benzinga
Ketamine Rapidly Reduces Depression, According To 'Most Comprehensive Review' Of Evidence — But Patient Experiences Suggest More Applications
January 29, 2022
From Benzinga
Psychedelic Medicine Co. PharmaTher Provides Update On Pipeline And Milestones For 2022
January 25, 2022
Tickers
PHRRF
From Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
From Stock Gumshoe
FDA Approves PharmaTher's Phase 2 Trial For Ketamine ALS Treatment
January 12, 2022
From Benzinga
Novamind Partners With Bienstar Wellness, Opening Door To Ibogaine Treatment For Addiction Disorders
December 02, 2021
From Benzinga
Seelos Raises $20M, Acquires Ketamine Tech, And Announces New Drug
December 02, 2021
From Benzinga
United Arab Emirate: Drug Reform And Treatment Programs In Bid To Keep Investors & Tourists Happy
November 29, 2021
Tickers
UAE
From Benzinga
NY's Lenox Hill Hospital With Cybin-Awarded Grant Will Provide Psychedelic Therapy To City's Underserved
November 23, 2021
Tickers
CYBN
From Benzinga
Psychedelic Companies Keenly Aware Of Creating Therapies As Healthcare Reimbursement Possibility Looms
November 22, 2021
Tickers
FTRP
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.